Enhancement of solubility of poorly water soluble anti hypertensive drug by nanosizing approach

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue SUPPL., 2012, Pages 40-41

  Thakar, Divyesh ^a   Bharadia, Praful ^a   Pandya, Vikram ^a  

^a BS Patel Pharmacy College   (India)

Author keywords

lyophilised; Nanosuspension; solubility; zeta potential

Indexed keywords

TELMISARTAN;

CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DRUG FORMULATION; DRUG SOLUBILITY; PARTICLE SIZE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SUSPENSION; ZETA POTENTIAL;

EID: 84860486007     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.94137     Document Type: Conference Paper

References (4)

1. Verma S, Lanb Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009; 377: 185-198.
2. Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003; 18: 113-120. (Pubitemid 36184748)
3. Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug f ormulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. 2001; 47: 3-19. (Pubitemid 32209229)
4. Konan YN, Gurny R, Alleman E. Preparation and characterization of sterile and freeze dried sub-200 nm nanoparticles. Int. J. Pharm. 2002; 233: 239-252 (Pubitemid 34230436)